These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35051498)

  • 1. Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19.
    Khan WH; Khan N; Mishra A; Gupta S; Bansode V; Mehta D; Bhambure R; Ansari MA; Das S; Rathore AS
    Int J Biol Macromol; 2022 Mar; 200():428-437. PubMed ID: 35051498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of ELISA Using Total Antibody against Plant-Expressed Recombinant Nucleocapsid Protein of SARS-CoV-2.
    Tariq M; Hur J; Seo JW; Kim DY; Yun NR; Lee YM; Bang MS; Hwang SY; Kim CM; Lee JH; Song KH; Lee H; Jung J; Park JY; Kim HB; Kim ES; Lee S; Kim DM
    Microbiol Spectr; 2021 Dec; 9(3):e0067221. PubMed ID: 34817278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
    Djukic T; Mladenovic M; Stanic-Vucinic D; Radosavljevic J; Smiljanic K; Sabljic L; Devic M; Cujic D; Vasovic T; Simovic A; Radomirovic M; Cirkovic Velickovic T
    Virology; 2021 May; 557():15-22. PubMed ID: 33582454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection.
    Li G; Li W; Fang X; Song X; Teng S; Ren Z; Hu D; Zhou S; Wu G; Li K
    Protein Expr Purif; 2021 Oct; 186():105908. PubMed ID: 34048905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level SARS-CoV-2 nucleocapsid refolding using mild condition for inclusion bodies solubilization: Application of high pressure at pH 9.0.
    Chura-Chambi RM; Prieto-da-Silva ARB; Di Lela MM; Oliveira JE; Abreu PEA; Meireles LR; de Andrade Junior HF; Morganti L
    PLoS One; 2022; 17(2):e0262591. PubMed ID: 35113919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients.
    Yang L; Xu Q; Yang B; Li J; Dong R; Da J; Ye Z; Xu Y; Zhou H; Zhang X; Liu L; Zha Y; Yu F
    BMC Microbiol; 2021 Dec; 21(1):351. PubMed ID: 34922455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An indirect ELISA for detecting anti-SARS-CoV-2 antibodies in human sera using a baculovirus-expressed recombinant nucleocapsid antigen.
    Fogaça MBT; Crispim GJB; Saavedra DP; Lopes-Luz L; da Silva LA; de Camargo BR; Guimarães RA; Nagata T; Ribeiro BM; Bührer-Sékula S
    Biologicals; 2024 May; 86():101769. PubMed ID: 38759304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of antigens expressed in Nicotiana benthamiana plant and Escherichia coli for the SARS-CoV-2 IgG antibody detection by ELISA.
    Fogaça MBT; Lopes-Luz L; Saavedra DP; de Oliveira NKAB; Jesus Sousa MB; Perez JDP; de Andrade IA; Crispim GJB; Pinto LDS; Ferreira MRA; Ribeiro BM; Nagata T; Conceição FR; Stefani MMA; Bührer-Sékula S
    J Virol Methods; 2024 Sep; 329():114969. PubMed ID: 38834144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion.
    Conzentino MS; Forchhammer K; Souza EM; Pedrosa FO; Nogueira MB; Raboni SM; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Fornazari B; Morales HMP; Celedon PAF; Lima CVP; Mattar SB; Lin VH; Morello LG; Marchini FK; Reis RA; Huergo LF
    Braz J Microbiol; 2021 Dec; 52(4):2069-2073. PubMed ID: 34342836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development.
    Cerutti H; Ricci V; Tesi G; Soldatini C; Castria M; Vaccaro MN; Tornesi S; Toppi S; Verdiani S; Brogi A
    J Clin Lab Anal; 2021 Apr; 35(4):e23735. PubMed ID: 33608968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.
    Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
    Tozetto-Mendoza TR; Kanunfre KA; Vilas-Boas LS; Sanchez Espinoza EP; Paião HGO; Rocha MC; de Paula AV; de Oliveira MS; Zampelli DB; Vieira JM; Buss L; Costa SF; Sabino EC; Witkin SS; Okay TS; Mendes-Correa MC
    J Virol Methods; 2021 Apr; 290():114064. PubMed ID: 33453299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.
    Terry JS; Anderson LB; Scherman MS; McAlister CE; Perera R; Schountz T; Geiss BJ
    Virology; 2021 Jun; 558():28-37. PubMed ID: 33714753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA.
    Kasetsirikul S; Umer M; Soda N; Sreejith KR; Shiddiky MJA; Nguyen NT
    Analyst; 2020 Nov; 145(23):7680-7686. PubMed ID: 32975254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein.
    Yang Q; Yan M; Lin J; Lu Y; Lin S; Li Z; Wang H; Yang J; Zhang N; Chen X
    PeerJ; 2024; 12():e17846. PubMed ID: 39224822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.
    Zhang L; Zheng B; Gao X; Zhang L; Pan H; Qiao Y; Suo G; Zhu F
    Front Immunol; 2020; 11():595970. PubMed ID: 33281824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
    Favresse J; Cadrobbi J; Eucher C; Elsen M; Laffineur K; Dogné JM; Douxfils J
    J Med Virol; 2021 Apr; 93(4):2262-2269. PubMed ID: 33200836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
    Yue L; Cao H; Xie T; Long R; Li H; Yang T; Yan M; Xie Z
    J Med Virol; 2021 Mar; 93(3):1732-1738. PubMed ID: 32965677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process development and characterization of recombinant nucleocapsid protein for its application on COVID-19 diagnosis.
    Vidal LEL; Figueira-Mansur J; Jurgilas PB; Argondizzo APC; Pestana CP; Martins FO; da Silva Junior HC; Miguez M; Loureiro BO; Marques CFS; Trinta KS; da Silva LBR; de Mello MB; da Silva ED; Bastos RC; Esteves G
    Protein Expr Purif; 2023 Jul; 207():106263. PubMed ID: 36921810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.